Edition:
United States

Pharming Group NV (PHAR.AS)

PHAR.AS on Amsterdam Stock Exchange

1.20EUR
14 Dec 2017
Change (% chg)

-- (--)
Prev Close
€1.20
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
30,747,314
52-wk High
€1.38
52-wk Low
€0.22

Select another date:

Tue, Dec 5 2017

BRIEF-Pharming Group Announces Significant Conversion Of Its Ordinary Convertible Bonds

* PHARMING ANNOUNCES SIGNIFICANT CONVERSION OF ITS ORDINARY CONVERTIBLE BONDS

BRIEF-Pharming Submits License Application to FDA for Ruconest

* PHARMING SUBMITS SUPPLEMENTAL BIOLOGICS LICENSE APPLICATION TO FDA FOR RUCONEST® FOR PROPHYLAXIS OF HEREDITARY ANGIOEDEMA ATTACKS

BRIEF-Pharming Group Q3 net result swings to profit of 7.5 million euros from Q2

* ‍Q3 NET RESULT IMPROVED TO EUR 7.5 MILLION LOSS COMPARED WITH A LOSS OF EUR 24.5 MILLION IN Q2​

BRIEF-Pharming Group announces positive data from paediatric clinical trial of Ruconest

* PHARMING ANNOUNCES POSITIVE DATA FROM PAEDIATRIC CLINICAL TRIAL WITH RUCONEST®

BRIEF-Pharming Group partners with Inceptua Medicines Access

* PHARMING GROUP N.V. AND HAEI INTERNATIONAL PATIENT ORGANIZATION ANNOUNCE PARTNERSHIP WITH INCEPTUA MEDICINES ACCESS FOR "HAEI GLOBAL ACCESS PROGRAM"

BRIEF-Pharming announces conclusion of FDA end of phase 2 interactions on Ruconest

* PHARMING ANNOUNCES CONCLUSION OF FDA END OF PHASE 2 INTERACTIONS ON RUCONEST FOR PROPHYLAXIS OF HAE

BRIEF-Pharming Group announces cashless warrant exercises and conversions of its ordinary bonds into shares

* ANNOUNCES CASHLESS WARRANT EXERCISES AND CONVERSIONS OF ITS ORDINARY BONDS INTO SHARES

BRIEF-Pharming Group H1 net loss widens to 30.2 million euros

* SAID ON THURSDAY THAT REVENUES FROM PRODUCT SALES FOR THE HALF YEAR INCREASED BY 617 PCT TO EUR 30.1 MILLION (HY 2016: EUR 4.2 MILLION)

BRIEF-Pharming announces publication of Ruconest prophylactic data in The Lancet

* PHARMING ANNOUNCES PUBLICATION OF RUCONEST PROPHYLACTIC DATA IN THE LANCET Source text for Eikon: Further company coverage: (Gdynia Newsroom)

BRIEF-Pharming group announces completion of replacement of its 100 million dollars bridge finance

* ANNOUNCES THAT IT HAS COMPLETED REPLACEMENT OF ITS RECENTLY ANNOUNCED US$100 MILLION BRIDGE FINANCE WITH ORBIMED ADVISORS

Select another date: